S
RCKT icon

SignatureFD’s Rocket Pharmaceuticals RCKT Stock Holding History

SignatureFD’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.41K Sell
2,460
-8,725
-78% -$29K ﹤0.01% 2702
2026
Q1 		$40K Sell
11,185
-2,307
-17% -$9.17K ﹤0.01% 1861
2025
Q4 		$47.4K Buy
13,492
+1,971
+17% +$6.75K ﹤0.01% 1683
2025
Q3 		$37.6K Buy
11,521
+7,962
+224% +$25.1K ﹤0.01% 1793
2025
Q2 		$8.72K Sell
3,559
-5,465
-61% -$27.7K ﹤0.01% 2398
2025
Q1 		$60.2K Buy
9,024
+4,108
+84% +$40.6K ﹤0.01% 1473
2024
Q4 		$61.8K Buy
4,916
+3,745
+320% +$56.4K ﹤0.01% 1463
2024
Q3 		$21.6K Buy
1,171
+315
+37% +$6.45K ﹤0.01% 2003
2024
Q2 		$18.4K Buy
856
+20
+2% +$459 ﹤0.01% 2004
2024
Q1 		$22.5K Buy
836
+8
+1% +$227 ﹤0.01% 1945
2023
Q4 		$24.8K Sell
828
-68
-8% -$1.5K ﹤0.01% 1814
2023
Q3 		$18.4K Buy
896
+397
+80% +$7.22K ﹤0.01% 1893
2023
Q2 		$9.91K Buy
499
+82
+20% +$1.66K ﹤0.01% 2239
2023
Q1 		$7.14K Hold
417
– – ﹤0.01% 2363
2022
Q4 		$8.16K Hold
417
– – ﹤0.01% 2242
2022
Q3 		$7K Hold
417
– – ﹤0.01% 2266
2022
Q2 		$6K Buy
417
+153
+58% +$1.82K ﹤0.01% 2395
2022
Q1 		$4K Buy
264
+242
+1,100% +$4.18K ﹤0.01% 2613
2021
Q4 		$0 Buy
22
+4
+22% +$109 ﹤0.01% 3235
2021
Q3 		$1K Sell
18
-13
-42% -$473 ﹤0.01% 2899
2021
Q2 		$1K Buy
+31
New +$1.35K ﹤0.01% 2804
2021
Q1 		– Sell
-32
Closed -$2K – 2815
2020
Q4 		$2K Buy
+32
New +$1.17K ﹤0.01% 2300
2020
Q2 		– Sell
-56
Closed -$1K – 2635
2020
Q1 		$1K Hold
56
– – ﹤0.01% 2177
2019
Q4 		$1K Buy
+56
New +$935 ﹤0.01% 2082

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

SignatureFD's RCKT Position: Q2 2026 in Review

SignatureFD reduced its Rocket Pharmaceuticals (RCKT) stake by 78% in Q2 2026, selling an estimated $29K and leaving 2,460 shares worth $8.41K. The position accounts for ﹤0.01% of the portfolio, ranked #2702.

SignatureFD first reported a position in RCKT in Q4 2019 and has held it in 24 quarters since. The position peaked at $61.8K in Q4 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • SignatureFD held 2,460 shares of Rocket Pharmaceuticals worth $8.41K as of Q2 2026.
  • SignatureFD sold 8,725 Rocket Pharmaceuticals shares in Q2 2026, an estimated $29K.
  • Rocket Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2702 holding.
  • SignatureFD first reported a position in Rocket Pharmaceuticals in Q4 2019 and has held it in 24 quarters since.
  • SignatureFD's Rocket Pharmaceuticals position peaked at $61.8K in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.